Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2016) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 12.597 Q1 | 391 | 257 | 625 | 8837 | 7380 | 260 | 11.64 | 34.39 |  |
| 2 | Trends in Pharmacological Sciences | journal | 5.350 Q1 | 244 | 97 | 267 | 8367 | 2852 | 211 | 11.06 | 86.26 | |
| 3 | Therapeutic Advances in Vaccines | journal | 1.810 Q1 | 5 | 0 | 6 | 0 | 62 | 6 | 10.33 | 0.00 | |
| 4 | Natural Product Reports | journal | 3.534 Q1 | 211 | 77 | 233 | 10320 | 2406 | 227 | 10.04 | 134.03 | |
| 5 | Particle and Fibre Toxicology | journal | 2.755 Q1 | 119 | 67 | 171 | 4492 | 1746 | 166 | 9.10 | 67.04 | |
| 6 | Drug Discovery Today | journal | 2.170 Q1 | 215 | 209 | 586 | 15377 | 3856 | 544 | 6.41 | 73.57 | |
| 7 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.987 Q1 | 99 | 19 | 41 | 1932 | 274 | 41 | 6.22 | 101.68 | |
| 8 | Nanotoxicology | journal | 1.596 Q1 | 107 | 146 | 273 | 8051 | 1714 | 266 | 6.11 | 55.14 | |
| 9 | Neuropsychopharmacology | journal | 3.747 Q1 | 249 | 323 | 906 | 18423 | 5916 | 859 | 6.06 | 57.04 | |
| 10 | Expert Opinion on Drug Delivery | journal | 1.488 Q1 | 133 | 147 | 406 | 11820 | 2413 | 397 | 5.70 | 80.41 | |
| 11 | Critical Reviews in Toxicology | journal | 1.809 Q1 | 129 | 44 | 127 | 4733 | 717 | 118 | 5.51 | 107.57 | |
| 12 | Environmental Pollution | journal | 1.827 Q1 | 301 | 945 | 1435 | 51441 | 8146 | 1398 | 5.36 | 54.43 | |
| 13 | Journal of Nanobiotechnology | journal | 1.234 Q1 | 109 | 80 | 199 | 4555 | 1072 | 198 | 5.28 | 56.94 | |
| 14 | Neuropharmacology | journal | 2.355 Q1 | 191 | 433 | 1229 | 30501 | 6354 | 1206 | 5.25 | 70.44 | |
| 15 | Journal for ImmunoTherapy of Cancer | journal | 2.668 Q1 | 117 | 90 | 146 | 3979 | 767 | 138 | 5.18 | 44.21 | |
| 16 | Therapeutic Advances in Neurological Disorders | journal | 1.442 Q1 | 68 | 47 | 86 | 2043 | 394 | 82 | 4.87 | 43.47 | |
| 17 | Emerging Microbes and Infections | journal | 2.394 Q1 | 94 | 87 | 133 | 3185 | 656 | 112 | 4.76 | 36.61 | |
| 18 | Journal of Psychopharmacology | journal | 2.095 Q1 | 135 | 140 | 391 | 8640 | 1810 | 372 | 4.69 | 61.71 | |
| 19 | Clinical Pharmacokinetics | journal | 1.599 Q1 | 184 | 110 | 269 | 6748 | 1381 | 244 | 4.68 | 61.35 | |
| 20 | Journal of Antimicrobial Chemotherapy | journal | 2.283 Q1 | 221 | 579 | 1597 | 17638 | 7321 | 1368 | 4.61 | 30.46 | |
| 21 | Expert Opinion on Therapeutic Targets | journal | 1.765 Q1 | 106 | 119 | 377 | 12656 | 1702 | 366 | 4.53 | 106.35 | |
| 22 | International Journal of Neuropsychopharmacology | journal | 1.997 Q1 | 125 | 118 | 598 | 6544 | 2678 | 587 | 4.38 | 55.46 | |
| 23 | Toxicological Sciences | journal | 1.629 Q1 | 207 | 237 | 796 | 11380 | 3591 | 757 | 4.26 | 48.02 | |
| 24 | Food and Chemical Toxicology | journal | 1.351 Q1 | 203 | 324 | 1576 | 18222 | 6729 | 1493 | 4.03 | 56.24 | |
| 25 | Protein and Cell | journal | 1.790 Q1 | 94 | 99 | 320 | 3851 | 1173 | 280 | 4.01 | 38.90 | |
| 26 | Pharmacogenomics Journal | journal | 1.377 Q1 | 95 | 76 | 227 | 3861 | 966 | 227 | 3.87 | 50.80 | |
| 27 | Drugs in Context | journal | 0.718 Q2 | 36 | 11 | 40 | 375 | 118 | 36 | 3.81 | 34.09 | |
| 28 | Expert Opinion on Investigational Drugs | journal | 1.210 Q1 | 117 | 126 | 411 | 11124 | 1545 | 405 | 3.80 | 88.29 | |
| 29 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.873 Q2 | 92 | 317 | 427 | 14565 | 1503 | 426 | 3.71 | 45.95 | |
| 30 | EPMA Journal | journal | 0.814 Q2 | 52 | 23 | 54 | 1479 | 245 | 54 | 3.70 | 64.30 | |
| 31 | Expert Opinion on Drug Discovery | journal | 1.116 Q1 | 84 | 105 | 306 | 9743 | 1146 | 304 | 3.68 | 92.79 | |
| 32 | Phytotherapy Research | journal | 1.016 Q2 | 158 | 217 | 775 | 11891 | 2794 | 770 | 3.61 | 54.80 | |
| 33 | Drug Testing and Analysis | journal | 1.027 Q1 | 67 | 144 | 427 | 4864 | 1326 | 400 | 3.59 | 33.78 | |
| 34 | Drug Safety | journal | 1.454 Q1 | 140 | 105 | 313 | 5877 | 1117 | 270 | 3.47 | 55.97 | |
| 35 | PharmacoEconomics | journal | 1.797 Q1 | 118 | 112 | 311 | 4712 | 1002 | 258 | 3.45 | 42.07 | |
| 36 | British Journal of Clinical Pharmacology | journal | 1.543 Q1 | 167 | 297 | 820 | 12341 | 3147 | 713 | 3.44 | 41.55 | |
| 37 | Expert Opinion on Biological Therapy | journal | 1.167 Q1 | 102 | 139 | 502 | 11318 | 1752 | 489 | 3.43 | 81.42 | |
| 38 | Human Genomics | journal | 1.770 Q1 | 68 | 37 | 76 | 1003 | 264 | 74 | 3.42 | 27.11 | |
| 39 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.928 Q2 | 100 | 138 | 403 | 11225 | 1389 | 399 | 3.40 | 81.34 | |
| 40 | Expert Opinion on Pharmacotherapy | journal | 1.014 Q2 | 93 | 238 | 734 | 17781 | 2325 | 715 | 3.40 | 74.71 | |
| 41 | Addictive Behaviors | journal | 1.548 Q1 | 149 | 256 | 868 | 10607 | 2906 | 861 | 3.36 | 41.43 | |
| 42 | Journal of Applied Toxicology | journal | 0.922 Q2 | 103 | 157 | 478 | 8154 | 1574 | 476 | 3.35 | 51.94 | |
| 43 | CNS Neuroscience and Therapeutics | journal | 1.567 Q1 | 91 | 128 | 425 | 6031 | 1514 | 324 | 3.34 | 47.12 | |
| 44 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 141 | 416 | 11331 | 1366 | 386 | 3.31 | 80.36 | |
| 45 | Toxicology in Vitro | journal | 1.025 Q2 | 125 | 188 | 754 | 9172 | 2574 | 740 | 3.24 | 48.79 | |
| 46 | Drug Delivery | journal | 0.649 Q2 | 95 | 372 | 221 | 16835 | 751 | 221 | 3.23 | 45.26 | |
| 47 | Expert Opinion on Emerging Drugs | journal | 0.762 Q2 | 54 | 38 | 131 | 3609 | 377 | 127 | 3.21 | 94.97 | |
| 48 | BioDrugs | journal | 1.035 Q2 | 79 | 48 | 139 | 2995 | 476 | 131 | 3.18 | 62.40 | |
| 49 | Expert Opinion on Therapeutic Patents | journal | 1.057 Q1 | 88 | 110 | 328 | 9821 | 1305 | 325 | 3.16 | 89.28 | |
| 50 | Bioorganic and Medicinal Chemistry | journal | 0.984 Q1 | 187 | 660 | 2274 | 28868 | 7176 | 2262 | 3.10 | 43.74 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data